Senores Pharmaceuticals Limited has informed the Exchange regarding audio recordings of Earnings Conference Call for the quarter and financial year ended March 31, 2026.
SENORES · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Senores Pharmaceuticals has submitted its earnings conference call recording held on May 14, 2026, following the audited financial results for Q4 and full FY ended March 31, 2026. The call was attended by analysts, institutional investors, and other investors. The company has made the audio recording available on its investor relations website. In compliance with SEBI regulations, the company has explicitly confirmed that no Unpublished Price Sensitive Information was shared or discussed during the call. This is a routine regulatory disclosure under SEBI LODR regulations 30 and 46.
This filing is procedural in nature and does not contain any new financial disclosures or forward-looking statements. The confirmation that no UPSI was shared provides regulatory compliance assurance. The actual content of the call (which could contain useful investor insights) is not summarized in this filing — investors would need to access the recording directly from the company's website for substantive takeaways.